The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge panel from that court found those laws to be unconstitutional. At the time of those decisions, AHA General Counsel Chad Golder stated, they “scream out for rehearing by the full Fourth Circuit. As the dissenting judge correctly points out, the majority rests its decision on arguments that the parties never made. It invents new theories of preemption that lack any basis in the law. It conflicts with the decisions of courts across the country. And it is wrong. We look forward to it being overturned.”  

The full court of appeals will now reconsider those decisions. Two federal courts of appeals have upheld similar laws in Louisiana and Arkansas. The AHA filed amicus briefs in support of the West Virginia and Maryland laws in both the district court and the 4th Circuit. 

Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the…
Headline
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging…
Headline
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a…
Headline
The Department of Health and Human Services’ Health Resources and Services Administration Oct. 1 announced approval of 10 drug companies to participate in the…
Headline
The Centers for Medicare & Medicaid Services’ 340B Part D claims data repository became available Oct. 1 for voluntary data submissions. While data…